信息型常见毒物质谱用户库的建立及其在毒物快速筛选上的应用研究

质谱定性是目前世界上最通用的定性分析方法之一,在法庭科学领域毒物分析实践中,质谱一直是对未知样品进行药毒物筛选检测的利器.     

二维液相色谱在药物和毒物分析中的应用进展

生物样品中药物、毒物及内源性物质的定性与定量分析在生命科学和药物研发中发挥重要作用。生物样品的基质复杂,干扰物多,待测物浓度与内源性物质相比明显偏低,且样品取样量少,因此要求生物分析方法的特异性强、灵敏度高、重现性好。二维液相色谱技术具有峰容量大、显著降低复杂样品的基质效应和残留现象,及可以实现样品分析的自动化等特点,已成为生物样品分离分析的有力工具,在环境、食品和药物分析中得到广泛应用。本文在简要介绍了二维液相色谱原理装置基础上,对其在生物样品中药物、毒物和内源性物质分析中的应用进展进行了综述。     

高通量药物筛选现代检测技术研究进展

高通量药物筛选是发现创新药物的重要技术途径.高通量筛选结果必须通过适当的检测方法才能反映出来,检测技术是实现高通量药物筛选的基础.本文综述了近年来有关光学分析、色谱分析、热分析、电化学分析、质谱、核磁共振等现代检测技术在高通量药物筛选研究中的进展.     

基于微流控芯片-质谱联用的细胞分析研究进展

微流控芯片与质谱联用为细胞研究提供了一个很好的研究平台.质谱的高灵敏度和对化合物独特的鉴别能力可以从复杂的化学信息背景中筛选识别出微量目标物,是细胞分析理想的检测手段.本文重点综述了近年来基于微流控芯片-质谱联用技术的细胞研究进展,从芯片-电喷雾质谱(ESI-MS)接口技术、集成化的样品前处理技术、细胞的药物代谢和细胞相互作用研究及基质辅助激光解吸电离质谱(MALDI-MS)的细胞分析应用等方面总结了最新的方法和技术发展.并展望了芯片-质谱联用新技术应用于细胞分析的可能性.     

原位衍生化技术在液相色谱和液相色谱-质谱联用分析中的应用

衍生化是将待分析物转化为更适合的物质形式以便于分析的有效手段。原位衍生化技术作为一种常用的柱前衍生化方法,可以在样品基质中同时完成分析物的萃取和衍生化,具有高效、灵敏和选择性好的优点。原位衍生化结合其他前处理技术广泛用于胺类、醛酮类、醇类、酚类、羧酸和巯基化合物的分析中,在生物、药物、食品、环境、化妆品分析等领域有广泛的应用。该文概述了原位衍生化的反应类型和代表性衍生试剂,综述了原位衍生化技术在液相色谱和液相色谱-质谱联用分析中的应用,并展望其发展趋势。     

利用亲和选择筛选法从组合化学库中筛选新药

组合化学方法可以产生大量的新化合物供新药筛选，但传统的逐一筛选法不能满足如此数量庞大的化合物，因此，针对混合物进行筛选显得非常重要，亲和选择筛选法利用药物作用的靶蛋白与潜在药物之间的亲和活性，使目标化合物与大量无亲和活性的化合物分离，然后只对有亲和活性的化合物进行结构鉴定，从而快速地从大量混合物中找到目标化合物，本文着重讨论了亲和选择筛选的的几种形，相应技术和在组合化学库筛选中的应用，亲和选择筛选大体分为两种方式：一种是将靶蛋白固定在支持物上，有亲和活力的化合物被保留，大量非亲和化合物被洗掉，另一种是在溶液中靶蛋白与混合物库孵育，然后利用受体配基复合物与不结合的游离化合性质的判别进行区分，亲和选择筛选法也适合于化合物的种类和含量都未知的天然提取物的筛选。     

未知酒用香精组分的分离与鉴定

普通蒸馏、分馏及红外光谱测定等是有机化学实验的基础技术;而未知物结构推断是一个综合利用其理化性质进行逻辑推理的过程。以现实生活中酒用香精组分的分离与鉴定实验为例,介绍如何通过不同实验技术的合理组合,以达到培养学生综合运用实验技术、科学分析实验结果、合理推断未知物结构能力的教学目的。     

抗体药物偶联物

单克隆抗体(单抗)药物是发展最为迅速的一个领域,在过去25年间大约有近30个单抗药物面世,主要用于抗癌和炎症;最近一种新的抗体药物偶联物(antibody-drug conjugate,ADC)技术取得了极大的成功。ADC是通过一个特殊的化学单元将单抗和小分子药物连接起来,充分利用抗体原有的亲合性和选择性,以及小分子药物的强药效,来降低小分子药物的毒性或延长小分子化合物的半衰期。随着一些链接技术的成熟和ADC药物上市,未来ADC将成为治疗疾病的重要手段。为了成功研制出一个新的ADC,需要对单抗、小分子药物和链接进行不断优化。一些新技术的问世也将极大促进ADC的发展。     

基于纳米材料的质谱成像研究进展

纳米材料种类的多样性以及性能的可调性为质谱分析方法的开发提供了多种可能。近年来,随着质谱分析技术的不断革新与发展,研究者逐步尝试将纳米材料辅助的质谱分析技术推进到质谱成像研究领域。利用纳米材料作为辅助电离介质和信号分子载体,质谱成像技术在实施未知物鉴别的同时可实现目标分子的精确定位,进而呈现生物分子、药物、环境污染物等在组织与细胞中的空间分布信息,为基于组织样本的病理生理学研究提供更直观的技术手段。本文总结了基于纳米材料的质谱成像技术的主要原理和研究进展,并对其未来发展及应用进行了展望。     

前体离子扫描法在快速筛查中药及保健食品中非法添加的5型磷酸二酯酶抑制剂及其未知衍生物中的应用

改造有明确疗效的药物,合成新的衍生物以避开法定检验方法是目前化学药物非法添加的趋势之一。本文提出将液相色谱-三重四极杆质谱联用仪的质谱前体离子扫描模式应用于中药及保健食品等复杂体系中非法添加药物衍生物的快速筛查策略,以5型磷酸二酯酶抑制剂为实验对象,通过分析该类化合物的结构和质谱特点将其分类,筛选各类共有的子离子碎片,优化质谱参数,建立了前体离子扫描模式的LC-MS筛查方法,讨论了质谱参数和碎片离子的选择对筛选结果的影响,并应用于实际样品的测定。结果表明,该方法既可以满足已知化合物的测定需要,又可以对复杂体系中未知的同类衍生物进行快速筛查,防止未知衍生物的漏检。该方法灵敏、专属、高效,值得进一步研究。     

邻苯二胺产品中针状未知化合物的结构鉴定

从邻苯二胺产品中分离出一种白色针状未知化合物,用液相色谱（ＨＰＬＣ）和气相色谱（ＧＣ）鉴定其纯度后,同时进行元素、红外光谱（ＩＲ）、紫外光谱（ＵＶ）、质谱（ＭＳ）、核磁共振（ＮＭＲ）氢谱及碳谱分析。根据分析的结果进行解析,最后确定未知针状不纯物中其主成分为２,１,３－苯并硫咪唑或２,１,３－硫二氮杂茚（Ｃ６Ｈ４Ｎ２Ｓ）（２,１,３－ｂｅｎｚｏｔｈ－ｉａｄｉａｚｏｌｅ）。     

减肥产品中非法添加西布曲明类似物的ESI-MS/MS检测与确证

通过分析西布曲明和减肥类健康产品中未知化合物质谱图的质谱信息,由高分辨串联质谱获得裂解碎片离子的精密质量数,质谱软件给出碎片的可能组成,推测了西布曲明和未知化合物的质谱裂解途径,进而推测出该化合物的结构。并通过合成该结构的化合物,采用液相色谱-串联质谱法对样品作确证检验,证实样品中添加了新的西布曲明类似物。该实验提供了一种可用于检测和确证健康产品中非法添加合成药物未知类似物的方法。     

Screening DNA Adducts by LC–ESI–MS–MS: Application to Screening New Adducts Formed from Acrylamide

A method for screening DNA adducts with unknown chemical structures was developed; it involves the use of liquid chromatography–electrospray ionization-tandem mass spectrometry (LC–ESI–MS–MS). In electrospray ionization (ESI) product ion mass spectra of guanine adducts, fragment ions were observed at m/z 152 and 135. Precursor ion scan analysis of these fragment ions indicated that the screening of DNA adducts would be possible. The developed method was used for the analysis of DNA adducts derived from acrylamide, which is not only a constituent of many commonly consumed foods but also a carcinogenic compound. We successfully discovered new guanine adducts. The results of this study indicate that the developed method is useful for screening new DNA adducts.     

Liquid Chromatography Tandem Mass Spectrometry and Nuclear Magnetic Resonance Spectroscopy of Magnesium (II) Gluconate Solution

Magnesium gluconate is a classical pharmaceutical compound used as a source of magnesium for the prevention and treatment of hypomagnesemia. To the best of our knowledge, a robust and reliable liquid chromatography tandem mass spectrometry technique has not yet been reported for the qualitative and quantitative analysis of magnesium gluconate. This study describes the method development for the LC–ESI–MS/MS analysis of magnesium gluconate using three different reversed-phase HPLC conditions (Method I–III) with comprehensive fragmentation pattern and the structural characterization by NMR spectroscopy. The LC–MS and NMR data were found in accordance with the structure of magnesium gluconate. When magnesium gluconate was dissolved in the acetonitrile and water–methanol solutions, it exists in situ in three different forms: magnesium gluconate itself, gluconic acid, and magnesium gluconate chelate with gluconic acid by a coordinate covalent bond. Method I exhibited pseudo-molecular ion peaks with more magnesium gluconate chelates with gluconic acid, while method II showed an adduct of magnesium gluconate with the solvent along with the molecular ion peak. There was no pseudo-molecular ion peaks found in method III. Thus, method III was found to be the more accurate, robust and reliable LC–MS method for the qualitative and quantitative analysis, structural characterization, and could also be suitable for the pharmacokinetic study of magnesium gluconate. The detailed fragmentation analysis might be useful for the structural characterization of unknown divalent organometallics.     

Pyrolysis GC/MS analysis of a bacterial population in a saline activated sludge system—Identification of the origin of the pyrolysis product 2-methylpyrimidine

During the investigation of problems with the physical handling of sludge from a saline activated sludge wastewater system, pyrolysis/GC/MS was used in an attempt to determine whether changes in the bacterial population in the sludge were occurring. The pyrolysis GC/MS analysis revealed an unknown peak among other typical bacterial pyrolysis products. This unknown was identified as 2-methylpyrimidine. This pyrolysis product was only found in appreciable amounts in samples from other saline systems but not in freshwater systems analyzed as points of comparison for the system of concern. Further investigation confirmed the source of 2-methylpyrimidine to be ectoine, a compound produced by halophilic bacteria as a compatible solute for osmoadaptation. Pyrolysis GC/MS was shown to be a useful tool to indicate the presence of ectoine in halophilic bacteria.     

Exact mass measurement of product ions for the structural confirmation and identification of unknown compounds using a quadrupole time-of-flight spectrometer: a simplified approach using combined tandem mass spectrometric functions

This article describes a simple method to perform lock mass corrected accurate mass measurements in tandem mass spectrometry (MS/MS) with a quadrupole time-of-flight (Q-TOF) mass spectrometer. The experimental approach consists of using the protonated molecule of a known compound, which is measured in a MS/MS function using low collision energy (no fragmentation), as mass calibrator. The unknown compound is acquired in MS/MS mode albeit using high collision energy. After the acquisition, the two MS/MS spectra of unknown and mass calibrator are combined, and the fragments of the unknown are lock mass corrected by using the protonated molecule of the mass calibrator. To prove this concept, 10 compounds were analyzed using this approach, the fragments interpreted and, where possible, related to structural data available in the literature. All the unequivocally assigned fragments were accurately mass measured with mass errors within appropriate limits, i.e. for m/z values <200 with a mass tolerance of 3 mDa while for m/z > 200 the mass tolerance is expressed as 10 ppm.     

Role of hypaphorine in the toxicity of Astragalus lusitanicus

Hypaphorine, an alpha-N,N,N-trimethyltryptophan betaine, was isolated, for the first time, from Astragalus lusitanicus Lam. (Fabaceae), a plant highly toxic for lambs and goats. This alkaloid was characterized by NMR and MS analysis. Hypaphorine was previously reported to be a convulsive poison. To confirm the toxicity, it was synthesized and tested in goats. Hypaphorine was shown to be non-toxic for goats even at a high dose of 2 g kg(-1) by oral administration.     

LC-MS/MS in the elucidation of an isomer of the recreational drug methylenedioxy ethylamphetamine: methylenedioxy dimethylamphetamine

This paper describes the surplus value of a quadrupole-orthogonal acceleration TOF mass spectrometer, coupled to a liquid chromatographic separation system, for the unequivocal identification and structural elucidation of an unknown compound in the field of designer drugs. In a patient sample set (blood, tissues, vitreous humor, etc.), analyzed with a dedicated liquid chromatographic-fluorescence detection method for the determination of methylenedioxy amphetamine, methylenedioxy methamphetamine, and methylenedioxy ethylamphetamine (MDEA), a "strange" inexplicable peak appeared at a retention time not corresponding to any of our reference materials. Based on the identical excitation and emission wavelengths in detection, and a retention behavior comparable to MDEA, it was assumed that this unknown compound was an isomer of the recreational drug MDEA. With a simple and straightforward methodological crossover between LC fluorescence detection and LC-MS/MS, additional information for structural elucidation was easily obtained. Chromatographic separation was achieved on a Hypersil BDS C18 column (fluorescence detection part) and on a Hypersil BDS phenyl column (mass spectrometric detection part). MS showed that the unknown compound's molecular mass was identical to that of MDEA, and, in addition, its fragmentation pattern too proved quite similar to that of MDEA. A thorough literature overview and study of the fragmentation pattern by means of the MS/MS spectrum led to an evidence-based hypothesis of 3,4-methylenedioxy N,N-dimethylamphetamine (MDDM) being the unknown compound. To confirm this hypothesis, MDDM was synthesized and its presence in our biological sample was finally demonstrated by co-injection with alternatively synthesized MDDM and MDEA. This application shows the synergism between LC and MS in the elucidation of unknown compounds, nevertheless emphasizing the essence of chromatographic separation when dealing with isomers.     

Ultra‐performance liquid chromatography tandem mass spectrometry for the rapid,simultaneous analysis of ziprasidone and its impurities

The separation and characterization of the unknown degradation product of second‐generation antipsychotic drug ziprasidone are essential for defining the genotoxic potential of the compound. The aim of this study was to develop a simple UHPLC method coupled with tandem mass spectrometry (MS/MS) for chemical characterization of an unknown degradant, and the separation and quantification of ziprasidone and its five main impurities (I–V) in the raw material and pharmaceuticals. Chromatographic conditions were optimized by experimental design. The MS/MS fragmentation conditions were optimized individually for each compound in order to obtain both specific fragments and high signal intensity. A rapid and sensitive UHPLC–MS/MS method was developed. All seven analytes were eluted within the 7 min run time. The best separation was obtained on the Acquity UPLC BEH C₁₈ (50 × 2.1 mm × 1.7 μm) column in gradient mode with ammonium‐formate buffer (10 mm ; pH 4.7) and acetonitrile as mobile phase, with the flow rate of 0.3 mL min^?1 and at the column temperature of 30°C. The new UHPLC–MS/MS method was fully validated and all validation parameters were confirmed. The fragmentation pathways and chemical characterization of an unknown degradant were proposed and it was confirmed that there are no structural alerts concerning genotoxicity.